Rubio, McCain Rout Primary Challengers

Rubio, McCain Rout Primary Challengers-morningconsult: Arizona Sen. John McCain and Florida Sen. Marco Rubio easily shook off their Republican primary challengers on Tuesday, setting the fields in what are expected to be two of the top Senate battlegrounds this cycle.

Conservative groups gear up for spending fight when Congress returns next week

Conservative groups gear up for spending fight when Congress returns next week-washingtonpost: Conservative groups are pushing congressional Republicans to punt the completion of this year’s spending work into early 2017 when a new president and Congress could negotiate a final deal.

House Conservatives Plot Coup Against Speaker Paul Ryan

House Conservatives Plot Coup Against Speaker Paul Ryan-huffingtonpost: House Speaker Paul Ryan’s re-election to his leadership post in January is fast turning into a potential showdown between establishment Republicans and conservatives looking to weaken the speaker and win changes to House rules.

Murphy, Rubio, McCain Enter Tuesday's Primaries as Heavy Favorites

Murphy, Rubio, McCain Enter Tuesday's Primaries as Heavy Favorites-rollcall: Leaders in the Republican and Democratic parties are expected to get their way Tuesday in a trio of marquee Senate primaries, each of which features an establishment-backed candidate who — by nearly all indications — will defeat a longshot challenger.

What to Watch for in Arizona, Florida Primaries

What to Watch for in Arizona, Florida Primaries-morningconsult: Voters in Arizona and Florida will head to the polls on Tuesday to determine the general election candidates in some of the country’s top House races and to solidify two marquee Senate contests that will likely decide the fate of the chamber’s majority.

House Oversight Committee investigating drugmaker Mylan over EpiPen price hike

House Oversight Committee investigating drugmaker Mylan over EpiPen price hike-washingtonpost: The House Oversight and Government Reform Committee has launched an investigation into drugmaker Mylan, which is facing increasing scrutiny for raising the price of the lifesaving EpiPen allergy injection.

Rank-and-file GOP fear lame-duck vote on pricey funding bill

Rank-and-file GOP fear lame-duck vote on pricey funding bill-thehill: Rank-and-file House Republicans are dreading voting on a huge spending deal in the lame-duck session — but they may have no choice.